Biden ad­min­is­tra­tion sig­nals that FDA may al­low abor­tion pill ac­cess via mail even af­ter the pan­dem­ic

Biden ad­min­is­tra­tion lawyers on Fri­day told a dis­trict court to hold off on de­cid­ing a ma­jor abor­tion pill case un­til De­cem­ber be­cause the FDA may re­move a decades-old pro­hi­bi­tion on dis­pens­ing such pills via mail.

While not­ing that the FDA tem­porar­i­ly lift­ed the in-per­son re­quire­ments dur­ing the pan­dem­ic last month, the Jus­tice De­part­ment lawyers said the FDA is now re­view­ing the risk eval­u­a­tion and mit­i­ga­tion strat­e­gy for the abor­tion pill, known as Mifeprex (mifepri­s­tone). The lawyers said they would pro­vide an up­date on the FDA’s progress by No­vem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER